Insmed (INSM) CEO William Lewis Sells $1.1 Million in Stock

William Lewis, the chair and CEO of Insmed (INSM), sold over $1.1 million worth of the company's stock. This transaction adds to the context of executive stock sales, which may influence investor perception. Details on the number of shares sold were not provided in the report. Such sales by executives can affect market confidence in a company's future performance and potentially impact stock prices. Investors may want to monitor this development as it might indicate the executives' outlook on the company's prospects.